Alcon agrees to acquire STAAR Surgical

Published on August 6, 2025
The planned acquisition of STAAR includes the EVO family of lenses (EVO ICL) for vision correction for patients with moderate to high myopia with or without astigmatism.
Continue reading on website
Other news

Birmingham Optical acquired by Advancing Eyecare

August 6, 2025
Birmingham Optical will continue to be led by the current management team, operating as a division of the North American ophthalmic instrument provider

Another drop in the presbyopia bucket: Dr Bloomenstein shares his excitement for the FDA approval of Vizz

August 6, 2025
With FDA approval of LENZ Therapeutics’ Vizz (LNZ100), optometrists now have a daily, non-invasive treatment option for presbyopia, giving patients more freedom and clinicians greater flexibility in care.